| 摘要 |
FIELD: medicine.SUBSTANCE: invention relates to oncogynaecology, haematology and genetics, and aims at predicting the risk of malignant growths in cervix and endometrium, ovaries, breasts. For method implementation in females of reproductive age determine signs of hereditary disorders (HDCT) in connective tissue in different systems and organs, at least one genetic and at least one anamnestic factor of thrombogenic risk (FTR) and genital tract contamination. In compliance with detected signs low, medium or high risk of malignant growths in female genital organs and mammary glands is defined.EFFECT: using the invention provides higher prediction accuracy and degree of malignant growths risk in cervix and endometrium, ovaries and breast.1 cl, 3 dwg, 3 tbl, 3 ex |
